Eribulin mesylate

Red

Brand Name(s):Halaven

Indication: Cancer – breast (locally advanced or metastatic after 2 previous chemotherapy)
treatments

Rationale:1,2,3

Considered:Nov-11

Review Date:Mar-23

Comments:
NICE TA 423
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens
Dec 16